These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11369842)

  • 41. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consequences of late referral on patient outcomes.
    Levin A
    Nephrol Dial Transplant; 2000; 15 Suppl 3():8-13. PubMed ID: 11032351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis.
    Ventura JE; Tavella N; Romero C; Petraglia A; Báez A; Muñoz L
    Nephrol Dial Transplant; 2002 Oct; 17(10):1795-801. PubMed ID: 12270987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
    Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
    Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
    Kutlay S; Dincer I; Sengül S; Nergizoglu G; Duman N; Ertürk S
    Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
    Schmid H; Schiffl H; Lederer SR
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Ritz E; Laville M; Bilous RW; O'Donoghue D; Scherhag A; Burger U; de Alvaro F;
    Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents.
    Io H; Aizawa M; Funabiki K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():7-13. PubMed ID: 26439537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .
    Akaishi M; Hiroe M; Hada Y; Suzuki M; Tsubakihara Y; Akizawa T;
    J Cardiol; 2013 Oct; 62(4):249-56. PubMed ID: 23787155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left ventricular hypertrophy and blood pressure control in automated and continuous ambulatory peritoneal dialysis patients.
    Ataş N; Erten Y; Okyay GU; Inal S; Topal S; Öneç K; Akyel A; Çelik B; Tavil Y; Bali M; Arınsoy T
    Ther Apher Dial; 2014 Jun; 18(3):297-304. PubMed ID: 24965296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation.
    Covic A; Mardare NG; Ardeleanu S; Prisada O; Gusbeth-Tatomir P; Goldsmith DJ
    J Nephrol; 2006; 19(6):783-93. PubMed ID: 17173253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Blood pressures values during evaluation of 24-h ambulatory blood pressure monitoring and left ventricular hypertrophy in patients with chronic renal failure treated with hemodialysis (HD)].
    Wanic-Kossowska M; Leman P; Kobelski M; Czekalski S
    Pol Arch Med Wewn; 2002 Jan; 107(1):29-35. PubMed ID: 12046341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic renal failure: a cardiovascular risk factor.
    Fort J
    Kidney Int Suppl; 2005 Dec; (99):S25-9. PubMed ID: 16336573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.